Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 158

1.

Biological markers of amyloid beta-related mechanisms in Alzheimer's disease.

Hampel H, Shen Y, Walsh DM, Aisen P, Shaw LM, Zetterberg H, Trojanowski JQ, Blennow K.

Exp Neurol. 2010 Jun;223(2):334-46. doi: 10.1016/j.expneurol.2009.09.024. Epub 2009 Oct 6. Review.

2.

Cerebrospinal fluid biomarkers for Alzheimer's disease.

Blennow K, Zetterberg H.

J Alzheimers Dis. 2009;18(2):413-7. doi: 10.3233/JAD-2009-1177. Review.

PMID:
19661632
3.

Amyloid beta and APP as biomarkers for Alzheimer's disease.

Zetterberg H, Blennow K, Hanse E.

Exp Gerontol. 2010 Jan;45(1):23-9. doi: 10.1016/j.exger.2009.08.002. Epub 2009 Aug 19. Review.

PMID:
19698775
4.

Core candidate neurochemical and imaging biomarkers of Alzheimer's disease.

Hampel H, Bürger K, Teipel SJ, Bokde AL, Zetterberg H, Blennow K.

Alzheimers Dement. 2008 Jan;4(1):38-48. doi: 10.1016/j.jalz.2007.08.006. Epub 2007 Dec 21. Review.

PMID:
18631949
5.

Biomarkers in amyloid-β immunotherapy trials in Alzheimer's disease.

Blennow K, Hampel H, Zetterberg H.

Neuropsychopharmacology. 2014 Jan;39(1):189-201. doi: 10.1038/npp.2013.154. Epub 2013 Jun 25. Review.

6.

Cerebrospinal fluid profiles of amyloid β-related biomarkers in Alzheimer's disease.

Rosén C, Andreasson U, Mattsson N, Marcusson J, Minthon L, Andreasen N, Blennow K, Zetterberg H.

Neuromolecular Med. 2012 Mar;14(1):65-73. doi: 10.1007/s12017-012-8171-4. Epub 2012 Feb 18.

PMID:
22350541
7.

Beta-site amyloid precursor protein cleaving enzyme 1 (BACE1) as a biological candidate marker of Alzheimer's disease.

Hampel H, Shen Y.

Scand J Clin Lab Invest. 2009;69(1):8-12. doi: 10.1080/00365510701864610. Review.

PMID:
18609117
8.

Aβ40 oligomers identified as a potential biomarker for the diagnosis of Alzheimer's disease.

Gao CM, Yam AY, Wang X, Magdangal E, Salisbury C, Peretz D, Zuckermann RN, Connolly MD, Hansson O, Minthon L, Zetterberg H, Blennow K, Fedynyshyn JP, Allauzen S.

PLoS One. 2010 Dec 30;5(12):e15725. doi: 10.1371/journal.pone.0015725.

9.

Amyloid-related biomarkers for Alzheimer's disease.

Andreasen N, Zetterberg H.

Curr Med Chem. 2008;15(8):766-71. Review.

PMID:
18393845
10.

Novel aβ isoforms in Alzheimer's disease - their role in diagnosis and treatment.

Portelius E, Mattsson N, Andreasson U, Blennow K, Zetterberg H.

Curr Pharm Des. 2011;17(25):2594-602. Review.

PMID:
21728980
11.

BACE1 gene variants do not influence BACE1 activity, levels of APP or Aβ isoforms in CSF in Alzheimer's disease.

Sjölander A, Zetterberg H, Andreasson U, Minthon L, Blennow K.

Mol Neurodegener. 2010 Sep 17;5:37. doi: 10.1186/1750-1326-5-37.

12.

Metals, membranes, and amyloid-β oligomers: key pieces in the Alzheimer's disease puzzle?

Watt AD, Villemagne VL, Barnham KJ.

J Alzheimers Dis. 2013;33 Suppl 1:S283-93. doi: 10.3233/JAD-2012-129017. Review.

PMID:
22699851
13.

Amyloid biomarkers in Alzheimer's disease.

Blennow K, Mattsson N, Schöll M, Hansson O, Zetterberg H.

Trends Pharmacol Sci. 2015 May;36(5):297-309. doi: 10.1016/j.tips.2015.03.002. Epub 2015 Apr 1. Review.

PMID:
25840462
14.

Correlations between soluble α/β forms of amyloid precursor protein and Aβ38, 40, and 42 in human cerebrospinal fluid.

Gabelle A, Roche S, Gény C, Bennys K, Labauge P, Tholance Y, Quadrio I, Tiers L, Gor B, Chaulet C, Vighetto A, Croisile B, Krolak-Salmon P, Touchon J, Perret-Liaudet A, Lehmann S.

Brain Res. 2010 Oct 21;1357:175-83. doi: 10.1016/j.brainres.2010.08.022. Epub 2010 Aug 14.

PMID:
20713025
15.

Clearing the amyloid in Alzheimer's: progress towards earlier diagnosis and effective treatments - an update for clinicians.

Asih PR, Chatterjee P, Verdile G, Gupta VB, Trengove RD, Martins RN.

Neurodegener Dis Manag. 2014;4(5):363-78. doi: 10.2217/nmt.14.29. Review.

PMID:
25405650
16.

Decrease in brain soluble amyloid precursor protein β (sAPPβ) in Alzheimer's disease cortex.

Wu G, Sankaranarayanan S, Hsieh SH, Simon AJ, Savage MJ.

J Neurosci Res. 2011 Jun;89(6):822-32. doi: 10.1002/jnr.22618. Epub 2011 Mar 23.

PMID:
21433051
17.

Amyloid imaging as a surrogate marker in clinical trials in Alzheimer's disease.

Scheinin NM, Scheinin M, Rinne JO.

Q J Nucl Med Mol Imaging. 2011 Jun;55(3):265-79. Review.

PMID:
21532540
18.

New tools for the study of Alzheimer's disease: what are biomarkers and morphometric markers teaching us?

Fjell AM, Walhovd KB.

Neuroscientist. 2011 Oct;17(5):592-605. doi: 10.1177/1073858410392586. Epub 2011 Apr 25. Review.

PMID:
21518812
19.

Recent approaches targeting beta-amyloid for therapeutic intervention of Alzheimer's disease.

Cho JE, Kim JR.

Recent Pat CNS Drug Discov. 2011 Sep 1;6(3):222-33. Review.

PMID:
21834780
20.

Age-dependent changes in brain, CSF, and plasma amyloid (beta) protein in the Tg2576 transgenic mouse model of Alzheimer's disease.

Kawarabayashi T, Younkin LH, Saido TC, Shoji M, Ashe KH, Younkin SG.

J Neurosci. 2001 Jan 15;21(2):372-81.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk